The Genome Editing Market is expected to grow significantly due to advancements in gene therapy technologies and the increasing demand for genetically modified organisms (GMOs) in agriculture and ...

This software use BLAT tool to compare the amplicon sequence with the expected target sequence. By analyzing the comparison, it evaluate the outcome of editing.

We can already tinker with human DNA to treat diseases. But being able to edit RNA allows for even more precision – and fewer ...

Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report). The ...

engages in the development of gene editing-based therapies. It provides scientific expertise, clinical development, and intellectual property position to unlock broad therapeutic applications of ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

DNA repair after Cas9 ... editing efficiency and precision, allowing zebrafish modeling for disease-related mutations which were previously limited by DNA sequence contexts. Emerging genome ...

2 Another highlighted Cerba Research’s unbiased sequencing approach accurately identifies vector integration sites using ...

Dr Matthew Kent at the Norwegian University of Life Sciences (NMBU) leads a new project to improve disease resistance in ...

Researchers have used whole-genome CRISPR interference screening to identify the “Achilles Heel” of drug-resistant ...